Accelerated chondrogenesis in nanofiber polymeric scaffolds embedded with BMP-2 genetically engineered chondrocytes

Robert T. Gorsline, Prasam Tangkawattana, John J. Lannutti, Mamoru Yamaguchi, Christopher C. Kaeding, Alicia L. Bertone

.

DOI: 10.4236/jbise.2010.39121                

Abstract

This study evaluated chondrogenesis within a nanofiber polymeric scaffold seeded with isolated untreated chondrocytes, isolated chondrocytes genetically engineered with adenoviral (Ad) bone morphogenetic protein (BMP)-2, or isolated chondrocytes genetically engineered with green fluorescent protein (Ad-GFP). Electrospun polycaprolactone scaffolds (150-200 m thickness, 700 m fiber diameter, 30 m pore size) were optimally seeded with 1 x 107 isolated chondrocytes by using a 20% serum gradient culture system. Chondrocyte-scaffold constructs (untreated, Ad-B- MP-2 and Ad-GFP) were generated from 5 adult horses, cultured in triplicate for 7 or 14 days, and quantitatively analyzed for cell proliferation (DNA content; Hoechst assay), viability, morphology (confocal microscopy), matrix production (proteoglycan content; DMMB assay), and mRNA expression of collagen I, collagen II, and aggrecan. Chondrocytes transduced with Ad-BMP-2 demonstrated greater cell numbers and significantly greater expression of chondrogenic markers including aggrecan, collagen II, and proteoglycan through 14 days of culture as compared to untransduced or Ad-GFP controls. This study demons- trated that chondrocytes can be driven to seed a polycaprolactone nanofiber scaffold by serum gradient and a polycaprolactone nanofiber scaffold containing Ad-BMP2 transduced chondrocytes resulted in grea- ter and accelerated chondrogenesis than controls. This cell engineered construct has potential use in one-step cartilage repair in vivo.

Keywords

Nanofiber; Scaffold; Chondrogenesis; BMP- 2; Adenovirus

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	Simon, T.M. and Jackson, D.W. (2006) Articular cartilage: Injury pathways and treatment options. Sports Medicine and Arthroscopy Review, 14(3), 146-154.
[2]	Chung, C. and Burdick, J.A. (2008) Engineering cartilage tissue. Advanced Drug Delivery Reviews, 60(2), 243-262.
[3]	Kino-Oka, M., Maeda, Y., Yamamoto, T., Sugawara, K. and Taya, M. (2005) A kinetic modeling of chondrocyte culture for manufacture of tissue-engineered cartilage. Journal of Bios-cience and Bioengineering, 99(3), 197-207.
[4]	Thorvaldsson, A., Stenhamre, H., Gatenholm, P. and Walken-strom, P. (2008) Electrospinning of highly porous scaffolds for cartilage regeneration. Biomacromolecules, 9(3), 1044-1049.
[5]	Li, W.J. and Tuan, R.S. (2009) Fabrication and application of nanofibrous scaffolds in tissue engineering. Current Protocols in Cell Biology, Chapter 25(25), Unit 25.2.
[6]	Jeong, C.G. and Hollister, S.J. (2010) A comparison of the influence of material on in vitro cartilage tissue engineering with PCL, PGS and POC 3D scaffold architecture seeded with chondrocytes. Biomaterials, 31(15), 4304-4312.
[7]	Martinez-Diaz, S., Garcia-Giralt, N., Lebourg, M., et al. (2010) In vivo evaluation of 3-dimensional polycaprolactone scaffolds for cartilage repair in rabbits. American Journal of Sports Medicine, 38(3), 509-519.
[8]	He, L., Liu, B., Xipeng, G., et al. (2009) Microstructure and properties of nano-fibrous PCL-b-PLLA scaffolds for cartilage tissue engineering. European Cells and Materials, 18, 63-74.
[9]	Martins, A., Pinho, E.D., Faria, S., et al. (2009) Surface mod-ification of electrospun polycaprolactone nanofiber meshes by plasma treatment to enhance biological performance. Small, 5(10), 1195-1206.
[10]	da Silva, M.A., Crawford, A., Mundy, J., et al. (2009) Evaluation of extracellular matrix formation in polycaprolactone and starch-compounded polycaprolactone nanofiber meshes when seeded with bovine articular chondrocytes. Tissue Engineering Part A, 15(2), 377-385.
[11]	Maher, S.A., Mauck, R.L., Rackwitz, L. and Tuan, R.S. (2010) A nanofibrous cell-seeded hydrogel promotes integration in a cartilage gap model. Journal of Tissue Engineering and Regenerative Medicine, 4(1), 25-29.
[12]	Li, W.J., Danielson, K.G., Alexander, P.G. and Tuan, R.S. (2003) Biological response of chondrocytes cultured in three-di- mensional nanofibrous poly (epsilon-caprolactone) scaffolds. Journal of Medical Materials Research, 67(4), 1105-1114.
[13]	Lee, J.J., Yu, H.S., Hong, S.J., Jeong, I., Jang, J.H. and Kim, H.W. (2009) Nanofibrous membrane of collagen- polycaprola- ctone for cell growth and tissue regeneration. Journal of Materials Science: Materials in Medicine, 20(9), 1927-1935.
[14]	Mierisch, C.M., Wilson, H.A., Turner, M.A., et al. (2003) Chondrocyte transplantation into articular cartilage defects with use of calcium alginate: the fate of the cells. Journal of Bone and Joint Surgery, 85A(9), 1757-1767.
[15]	Ito, Y., Fitzsimmons, J.S., Sanyal, A., Mello, M.A., Mukherjee, N. and O'Driscoll, S.W. (2001) Localization of chondrocyte precursors in periosteum. Osteoarthritis and Cartilage, 9(3), 215-223.
[16]	Li, J., Chen, Y., Mak, A.F., Tuan, R.S., Li, L. and Li, Y. (2009) A one-step method to fabricate PLLA scaffolds with deposition of bioactive hydroxyapatite and collagen using ice- based mi-croporogens. Acta Biomaterialia, 6(6), 2013-2019.
[17]	Mendes, S.C., Bezemer, J., Claase, M.B., et al. (2003) Ev alua-tion of two biodegradable polymeric systems as substrates for bone tissue engineering. Tissue Engineering, 9 (Suppl 1), 91-101.
[18]	Duling, R.R., Dupaix, R.B., Katsube, N. and Lannutti, J. (2008) Mechanical characterization of electrospun polycaprolac- tone (PCL): A potential scaffold for tissue engineering. Journal of Biomechanical Engineering, 130(1), 011006.
[19]	Gaumer, J., Prasad, A., Lee, D. and Lannutti, J. (2009) Struc-ture-function relationships and source-to-ground distance in electrospun polycaprolactone. Acta Biomaterialia, 5(5), 1552-1561.
[20]	Johnson, J., Niehaus, A., Nichols, S., et al. (2009) Electr- os-pun PCL in vitro: a microstructural basis for mechanical prop-erty changes. Journal of Biomaterials Sicence, Polymer Edition, 20(4), 467-481.
[21]	Li, W.J., Chiang, H., Kuo, T.F., Lee, H.S., Jiang, C.C. and Tuan, R.S. (2009) Evaluation of articular cartilage repair using biodegradable nanofibrous scaffolds in a swine model: A pilot study. Journal of Tissue Engineering and Regenerative Medi-cine, 3(1), 1-10.
[22]	Fecek, C., Yao, D., Kacorri, A., et al. (2008) Chondrogenic derivatives of embryonic stem cells seeded into 3D poly- ca-prolactone scaffolds generated cartilage tissue in vivo. Tissue Engineering Part A, 14(8), 1403-1413.
[23]	Nam, J., Rath, B., Knobloch, T.J., Lannutti, J.J. and Agarwal, S. (2009) Novel electrospun scaffolds for the molecular analysis of chondrocytes under dynamic compression. Tissue Engineering Part A, 15(3), 513-523.
[24]	Chang, K.Y., Cheng, L.W., Ho, G.H., Huang, Y.P. and Lee, Y.D. (2009) Fabrication and characterization of poly (gamma- glutamic acid)-graft-chondroitin sulfate/ polycaprolacto- ne porous scaffolds for cartilage tissue engineering. Acta Bioma-terialia, 5(6), 1937-1947.
[25]	Frisbie, D.D., Lu, Y., Kawcak, C.E., DiCarlo, E.F., Binette, F. and McIlwraith, C.W. (2009) In vivo evaluation of autologous cartilage fragment-loaded scaffolds implanted into equine ar-ticular defects and compared with autologous chondrocyte implantation. American Journal of Sports Medicine, 37 (Suppl 1), 71-80.
[26]	Kang, X., Xie, Y., Powell, H.M., et al. (2007) Adipogenesis of murine embryonic stem cells in a three-dimensional culture sys-tem using electrospun polymer scaffolds. Bio- materials, 28(3), 450-458.
[27]	Johnson, J., Nowicki, M.O., Lee, C.H., et al. (2009) Quantita-tive analysis of complex glioma cell migration on electrospun polycaprolactone using time-lapse microscopy. Tissue Engi-neering Part C, 15(4), 531-540.
[28]	Drilling, S., Gaumer, J. and Lannutti, J. (2009) Fabrication of burst pressure competent vascular grafts via electrospinning: Effects of microstructure. Journal of Biomedical Materials Research Part A, 88(4), 923-934.
[29]	Xian, C.J. and Foster, B.K. (2006) Repair of injured articular and growth plate cartilage using mesenchymal stem cells and chondrogenic gene therapy. Current Stem Cell Research & Therapy, 1(2), 213-229.
[30]	Puetzer, J.L., Petitte, J. and Loboa, E. (2010) Comparative review of growth factors for induction of 3-Dimensional in vitro chondrogenesis in human mesenchymal stem cells isolated from bone marrow and adipose tissue. Tissue Engineering Part B, 16(4), 435-444
[31]	Zachos, T., Diggs, A., Weisbrode, S., Bartlett, J. and Bertone, A. (2007) Mesenchymal stem cell-mediated gene delivery of bone morphogenetic protein-2 in an articular fracture model. Molecular Therapy, 15(8), 1543-1550.
[32]	van der Kraan, P.M., Davidson, E.N. and van den Berg, W.B. (2010) Bone morphogenetic proteins and articular cartilage to serve and protect or a wolf in sheep clothing's? Osteoarthritis and Cartilage, 18(6), 735-741.
[33]	Kaps, C., Bramlage, C., Smolian, H., et al. (2002) Bone mor-phogenetic proteins promote cartilage differentiation and protect engineered artificial cartilage from fibroblast invasion and destruction. Arthritis & Rheumatism, 46(1), 149-162.
[34]	Majumdar, M.K., Wang, E. and Morris, E.A. (2001) BMP-2 and BMP-9 promotes chondrogenic differentiation of human multipotential mesenchymal cells and overcomes the inhibitory effect of IL-1. Journal of Cell Physiology, 189(3), 275-284.
[35]	Glansbeek, H.L., van Beuningen, H.M., Vitters, E.L., Morris, E.A., van der Kraan, P.M. and van den Berg, W.B. (1997) Bone morphogenetic protein 2 stimulates articular cartilage proteoglycan synthesis in vivo but does not counteract inter-leukin-1alpha effects on proteoglycan synthesis and content. Arthritis & Rheumatism, 40(6), 1020-1028.
[36]	Smith, P., Shuler, F.D., Georgescu, H.I., et al. (2000) Genetic enhancement of matrix synthesis by articular chondrocytes: Comparison of different growth factor genes in the presence and absence of interleukin-1. Arthritis & Rheumatism, 43(5), 1156-1164.
[37]	Zachos, T.A., Shields, K.M. and Bertone, A.L. (2006) Gene-mediated osteogenic differentiation of stem cells by bone morphogenetic proteins-2 or -6. Journal of Orthopaedic Re-search, 24(6), 1279-1291.
[38]	Stankus, J.J., Guan, J., Fujimoto, K. and Wagner, W.R. (2006) Microintegrating smooth muscle cells into a biodegradable, elastomeric fiber matrix. Biomaterials, 27(5), 735-744.
[39]	Nam, J., Huang, Y., Agarwal, S. and Lannutti, J. (2008) Mate-rials selection and residual solvent retention in biodegradable electrospun fibers. Journal of Applied Polymer Science, 107(3), 1547-1554.
[40]	Lopez-Vidriero, E., Goulding, K.A., Simon, D.A., Sanchez, M. and Johnson, D.H. (2010) The use of platelet-rich plasma in arthroscopy and sports medicine: Optimizing the healing environment. Arthroscopy, 26(2), 269-278.
[41]	Sutter, W.W., Kaneps, A.J. and Bertone, A.L. (2004) Compar-ison of hematologic values and transforming gro- wth factorbeta and insulin-like growth factor concentrations in platelet concentrates obtained by use of buffy coat and apheresis me-thods from equine blood. American Journal of Veterinary Re-search, 65(7), 924-930.
[42]	Wilke, M.M., Nydam, D.V. and Nixon, A.J. (2007) Enhanced early chondrogenesis in articular defects following arthroscopic mesenchymal stem cell implantation in an equine model. Journal of Orthopaedic Research, 25(7), 913-925.
[43]	Santangelo, K.S., Baker, S.A., Nuovo, G., Dyce, J., Bartlett, J.S. and Bertone, A.L. (2007) Detectable reporter ge- ne expression following transduction of adenovirus and adeno-associated virus serotype 2 vectors within full-thickness osteoarthritic and unaffected canine cartilage in vitro and unaffected guinea pig cartilage in vivo. Journal of Orthopaedic Research, 28(2), 149-155.